We are live on
!
Find out more
MCAV
Meritech Capital Associates V Portfolio holdings
AUM
$141M
1-Year Est. Return
15.44%
This Fund
S&P 500
This Quarter
Est. Return
-20.43%
1 Year Est. Return
+15.44%
3 Year Est. Return
+37.35%
5 Year Est. Return
+8.8%
10 Year Est. Return
–
AUM
$314M
AUM Growth
-$103M
(-25%)
Cap. Flow
-$13.3M
Cap. Flow
% of AUM
-4.24%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 60.85% |
| 2 | Technology | 32.66% |
| 3 | Healthcare | 6.49% |
Similar funds
CL
SFS
CFGW
OFA
RB
KCM
WA
TM
Meritech Capital Associates V's Q3 2023 Portfolio in Review
As of Q3 2023, Meritech Capital Associates V held 6 positions worth $314M, down 25% from $418M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Meritech Capital Associates V withdrew a net $13.3M in Q3 2023, reducing 1 holding. Its largest reduction was 10x Genomics, cutting an estimated $13.3M.
By sector, the portfolio is most concentrated in Communication Services at 61% of assets, down from 64% a quarter earlier, followed by Technology and Healthcare.
- Meritech Capital Associates V's biggest Q3 2023 reduction was 10x Genomics, cutting an estimated $13.3M.
- Meritech Capital Associates V's ten largest holdings make up 100% of its $314M portfolio in Q3 2023.
- Meritech Capital Associates V opened 0 new positions and closed 0 in Q3 2023.
- Meritech Capital Associates V's portfolio value fell 25% quarter-over-quarter to $314M.
Based on Meritech Capital Associates V's 13F filing for Q3 2023, filed 14 Nov 2023.